West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 337,400 | 235,900 | 203,000 | 274,600 | 255,300 |
| Receivables | 288,200 | 253,200 | 200,500 | 181,400 | 179,000 |
| Inventories | 214,500 | 215,200 | 199,300 | 181,100 | 181,500 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 7,800 |
| Other current assets | 54,300 | 39,200 | 39,100 | 36,600 | 35,500 |
| TOTAL | $894,400 | $743,500 | $641,900 | $673,700 | $659,100 |
| Non-Current Assets | |||||
| PPE Net | 822,000 | 855,000 | 778,300 | 721,000 | 705,800 |
| Investments And Advances | 91,200 | 85,800 | 82,700 | 61,300 | 60,600 |
| Intangibles | 126,100 | 129,400 | 126,300 | 142,200 | 150,600 |
| Other Non-Current Assets | 45,200 | 49,100 | 87,500 | 96,900 | 93,600 |
| TOTAL | $1,084,500 | $1,119,300 | $1,074,800 | $1,021,400 | $1,010,600 |
| Total Assets | $1,978,900 | $1,862,800 | $1,716,700 | $1,695,100 | $1,669,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 130,400 | 138,100 | 122,000 | 119,800 | 103,100 |
| Accrued Expenses | 64,500 | 56,200 | 51,600 | 53,000 | 52,900 |
| Other current liabilities | 78,900 | 79,200 | 60,500 | 59,400 | 54,400 |
| TOTAL | $283,700 | $279,500 | $241,000 | $314,300 | $252,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 196,000 | 197,000 | 226,200 | 228,900 | 308,300 |
| Other Non-Current Liabilities | 89,800 | 96,000 | 122,800 | 115,600 | 136,300 |
| TOTAL | $298,900 | $303,400 | $358,200 | $356,900 | $460,300 |
| Total Liabilities | $582,600 | $582,900 | $599,200 | $671,200 | $712,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,186 | 73,987 | 73,260 | 72,334 | 71,495 |
| Common Shares | 18,800 | 18,800 | 18,400 | 18,100 | 17,800 |
| Retained earnings | 1,353,400 | 1,178,200 | 1,071,600 | 964,600 | 902,200 |
| Other shareholders' equity | -153,900 | -117,400 | -186,900 | -162,600 | -119,300 |
| TOTAL | $1,396,300 | $1,279,900 | $1,117,500 | $1,023,900 | $956,900 |
| Total Liabilities And Equity | $1,978,900 | $1,862,800 | $1,716,700 | $1,695,100 | $1,669,700 |